Geode Capital Management, LLC Re Shape Lifesciences Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.32 - $0.6 $2,799 - $5,248	8,748 Added 2.94%	306,611 $92,000
Q2 2022 Aug 12, 2022	BUY	$0.56 - $1.25 $9,651 - $21,542	17,234 Added 6.14%	297,863 $171,000
Q1 2022 May 13, 2022	BUY	$0.86 - $1.86 $47,242 - $102,175	54,933 Added 24.34%	280,629 $331,000
Q4 2021 Feb 11, 2022	BUY	$1.64 - $3.13 $256,343 - $489,240	156,307 Added 225.26%	225,696 $370,000
Q3 2021 Nov 12, 2021	BUY	$2.67 - $5.09 $123,119 - $234,710	46,112 Added 198.1%	69,389 $199,000

Q2 2021 Aug 13, 2021	BUY	$2.02 - $7.64 $47,019 - $177,836	23,277 New	23,277 $116,000

Ticker RSLS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,559,400
Market Cap $4.74M
Description
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.